News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions


2/12/2008 7:45:36 AM

CHICAGO -(Dow Jones)- Baxter International Inc. (BAX) has temporarily halted production of certain heparin vials amid reports of serious adverse reactions to the widely used, injectable blood thinner, including some deaths that may be related to the drug. The Deerfield, Ill., company has not broadened a prior recall of heparin, however, amid worries that such action would starve the market of a key tool that is used in a range of procedures, from dialysis to heart surgery. Heparin is a generic prescription drug, and Baxter is a major manufacturer that sells about 100,000 vials per day.

Read at CNN Money
Read at Reuters
Read at Medical News Today
Read at WebMD
Read at FDA

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES